315 related articles for article (PubMed ID: 23790165)
41. Ki-67 expression is increased in p16-expressing triple-negative breast carcinoma and correlates with p16 only in p53-negative tumors.
Sugianto J; Sarode V; Peng Y
Hum Pathol; 2014 Apr; 45(4):802-9. PubMed ID: 24560018
[TBL] [Abstract][Full Text] [Related]
42. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
43. Cytogenetic and proliferative potentials in meningiomas.
Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
[TBL] [Abstract][Full Text] [Related]
44. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.
Zlotta AR; Noel JC; Fayt I; Drowart A; Van Vooren JP; Huygen K; Simon J; Schulman CC
J Urol; 1999 Mar; 161(3):792-8. PubMed ID: 10022686
[TBL] [Abstract][Full Text] [Related]
45. Expression of minichromosome maintenance MCM6 protein in meningiomas is strongly correlated with histologic grade and clinical outcome.
Gauchotte G; Vigouroux C; Rech F; Battaglia-Hsu SF; Soudant M; Pinelli C; Civit T; Taillandier L; Vignaud JM; Bressenot A
Am J Surg Pathol; 2012 Feb; 36(2):283-91. PubMed ID: 22020044
[TBL] [Abstract][Full Text] [Related]
46. Assessment of candidate immunohistochemical prognostic markers of meningioma recurrence.
Csonka T; Murnyák B; Szepesi R; Bencze J; Bognár L; Klekner A; Hortobágyi T
Folia Neuropathol; 2016; 54(2):114-26. PubMed ID: 27543769
[TBL] [Abstract][Full Text] [Related]
47. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
48. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical study of MRP5 expression in meningiomas.
Alexiou GA; Goussia A; Ntoulia A; Zagorianakou P; Malamou-Mitsi V; Voulgaris S; Kyritsis AP
Cancer Chemother Pharmacol; 2013 Mar; 71(3):825-8. PubMed ID: 23271324
[TBL] [Abstract][Full Text] [Related]
50. Peritumoral Brain Edema in Meningiomas Depends on Aquaporin-4 Expression and Not on Tumor Grade, Tumor Volume, Cell Count, or Ki-67 Labeling Index.
Gawlitza M; Fiedler E; Schob S; Hoffmann KT; Surov A
Mol Imaging Biol; 2017 Apr; 19(2):298-304. PubMed ID: 27552812
[TBL] [Abstract][Full Text] [Related]
51. Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas.
Arikök AT; Onder E; Seçkin H; Kaçar A; Fesli R; Oğuz AS; Alper M
Brain Tumor Pathol; 2014 Apr; 31(2):94-100. PubMed ID: 23793814
[TBL] [Abstract][Full Text] [Related]
52. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
53. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
[TBL] [Abstract][Full Text] [Related]
54. Relationship between NF-κB, ER, PR, Her2/neu, Ki67, p53 expression in human breast cancer.
Shapochka DO; Zaletok SP; Gnidyuk MI
Exp Oncol; 2012 Dec; 34(4):358-63. PubMed ID: 23302996
[TBL] [Abstract][Full Text] [Related]
55. CD90 expression in atypical meningiomas and meningioma metastasis.
Scognamiglio G; D'Antonio A; Rossi G; Cavazza A; Camerlingo R; Pirozzi G; La Mantia E; Anniciello AM; Morabito A; Cantile M; Boscaino A; Sparano L; Botti G; Rocco G; Franco R
Am J Clin Pathol; 2014 Jun; 141(6):841-9. PubMed ID: 24838329
[TBL] [Abstract][Full Text] [Related]
56. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
[TBL] [Abstract][Full Text] [Related]
57. Elevated p53 expression in benign meningiomas protects against recurrence and may be indicative of senescence.
Hakin-Smith V; Battersby RD; Maltby EL; Timperley WR; Royds JA
Neuropathol Appl Neurobiol; 2001 Feb; 27(1):40-9. PubMed ID: 11299001
[TBL] [Abstract][Full Text] [Related]
58. Analysis of immunohistochemical expression of p53 and the proliferation marker Ki-67 antigen in skull base chordomas: relationships between their expression and prognosis.
Sakai K; Hongo K; Tanaka Y; Nakayama J
Brain Tumor Pathol; 2007; 24(2):57-62. PubMed ID: 18095132
[TBL] [Abstract][Full Text] [Related]
59. CD44 expression in human meningiomas: an immunohistochemical analysis.
Lewy-Trenda I; Omulecka A; Janczukowicz J; Papierz W
Pol J Pathol; 2004; 55(1):33-7. PubMed ID: 15195704
[TBL] [Abstract][Full Text] [Related]
60. Pediatric meningiomas an aggressive subset: a clinicopathological and immunohistochemical study.
Hui M; Uppin MS; Saradhi MV; Sahu BP; Purohit AK; Sundaram C
J Postgrad Med; 2015; 61(1):32-5. PubMed ID: 25511215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
